Hypothalamic-Pituitary Axis Function and Adrenal Insufficiency in COVID-19 Patients

Area of Science:

• Endocrinology
• Infectious Diseases
• Critical Care Medicine

Background:

• COVID-19 (caused by SARS-CoV-2) has caused millions of deaths globally.
• SARS-CoV-2 infection affects multiple organ systems, including endocrine organs.
• Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is a critical concern in COVID-19 patients.

Purpose of the Study:

• To review the literature on evaluating the HPA axis in COVID-19 patients.
• To highlight the importance of diagnosing adrenal insufficiency (AI) in the context of COVID-19.
• To discuss the challenges and diagnostic approaches for AI during SARS-CoV-2 infection.

Main Methods:

• Literature review focusing on HPA axis function in COVID-19.
• Analysis of pathogenetic mechanisms including immunogenic, vascular, and direct viral effects.
• Discussion of diagnostic challenges, including basal cortisol levels and ACTH stimulation tests.

Main Results:

• SARS-CoV-2 can lead to primary or secondary adrenal insufficiencies (AIs).
• Clinical manifestations of AI are often non-specific and overlap with COVID-19 symptoms.
• Diagnostic criteria for AI in critically ill COVID-19 patients lack consensus.

Conclusions:

• Adrenal insufficiency (AI) must be considered in all patients with COVID-19.
• Repeated basal cortisol measurements and ACTH stimulation tests are crucial for diagnosis.
• Prompt diagnosis and management of AI can prevent potentially fatal outcomes in COVID-19 patients.